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The molecular mechanisms behind the entry of the primordial follicle into the growing follicle pool remain poorly understood. To investigate
this process further, a microarray-based comparison was undertaken between 2-day postpartum mouse ovaries consisting of primordial follicles/
naked oocytes only and those with both primordial follicles and newly activated follicles (7-day postpartum). Gene candidates identified included
the chemoattractive cytokine stromal derived factor-1 (SDF1) and its receptor CXCR4. SDF1 and CXCR4 have been implicated in a variety of
physiological processes including the migration of embryonic germ cells to the gonads. SDF1-α expression increased with the developmental
stage of the follicle. Embryonic expression was found to be dichotomous post-germ cell migration, with low expression in the female.
Immunohistochemical studies nonetheless indicate that the autocrine pattern of expression ligand and receptor begins during embryonic life.
Addition of recombinant SDF1-α to neonatal mouse ovaries in vitro resulted in significantly higher follicle densities than for control ovaries.
TUNEL analysis indicated no detectable difference in populations of apoptotic cells of treated or control ovaries. Treated ovaries also contained a
significantly lower percentage of activated follicles as determined by measurement of oocyte diameter and morphological analysis. Treatment of
cultured ovaries with an inhibitor of SDF1-α, AMD3100, ablated the effect of SDF1-α. By retaining follicles in an unactivated state, SDF1/
CXCR4 signaling may play an important role in maintaining the size and longevity of the primordial follicle pool.
© 2006 Elsevier Inc. All rights reserved.Keywords: SDF1; cxcr12; cxcr4; Primordial follicle; Embryonic gonadIntroduction
The molecular mechanisms controlling the entry of the
primordial follicle into the growing follicle pool remain
obscure, yet a more complete understanding of the process
may aid in overcoming certain forms of female infertility. A
number of paracrine factors have been implicated in the
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doi:10.1016/j.ydbio.2006.02.012follicle growth. Leukemia inhibitory factor (LIF) (Nilsson et
al., 2002), basic fibroblast growth factor (bFGF) (Nilsson et
al., 2001), stem cell factor (SCF) (Parrott and Skinner, 1999),
and bone morphogenic protein-4 (Nilsson and Skinner, 2003)
and -7 (Lee et al., 2004) are positive regulators of the system,
while anti-Müllerian hormone (AMH) has been shown to
inhibit the primordial to primary transition (Durlinger et al.,
1999, 2002a).
Chemokines are a family of greater than 50 structurally
related, small molecular weight chemoattractive cytokines.
SDF1 (also called CXCL12) is a chemokine that was
originally identified as a molecule expressed by a bone-
marrow-derived stromal cell line that acted as a stimulator of
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thought to have a single receptor—the seven transmembrane
G-protein-coupled receptor CXCR4, which is also a corecep-
tor for the X4 strains of the human immunodeficiency virus
(Feng et al., 1996). Recent evidence however suggests SDF1
may bind and signal through other receptors including orphan
receptor RDC1 and syndecan-4 (Balabanian et al., 2005;
Charnaux et al., 2005). Constitutively expressed in a variety
of tissues, the pair are also widely expressed by malignant
cells (Balkwill, 2004; Pablos et al., 1999). Knockout models
have emphasized the importance of this signaling couple in
the development of B lymphocytes, GI tract blood vessel
development, heart septum formation, neuron localization
(Ma et al., 1998; Tachibana et al., 1998). Deletion of either
the CXCR4 or SDF1 genes results in embryonic lethality
(Nagasawa et al., 1996; Tachibana et al., 1998; Zou et al.,
1998). A role for the signaling axis has been established in
the migration of primordial germ cells from the hindgut to the
gonads, with SDF−/− mutant mice displaying delayed
migration and decreased numbers of primordial germ cells
in the gonads (Ara et al., 2003; Molyneaux et al., 2003;
Stebler et al., 2004). SDF1 exists in three transcript variant
forms, SDF1-α, -β, and -γ that arise by alternate splicing
from a single gene and correspond to proteins of 89, 93, and
119 amino acids respectively (Gleichmann et al., 2000; Jiang
et al., 1994). SDF-β differs from SDF-α by a four amino acid
extension at the carboxy terminus. Mouse SDF-α and -β are
greater than 92% identical to their human homologs (Shirozu
et al., 1995).
The ovarian processes of follicular atresia, ovulation,
corpus luteum formation and luteal regression are charac-
teristic of an inflammatory response, with the role of
leukocytes and their secretory products central to these
events (Bukulmez and Arici, 2000; Townson and Liptak,
2003a). As such, a number of chemokines have been
identified within the mammalian mouse adult ovary
including MCP-1 and RANTES and their receptors (Zhou
et al., 2004). The identification of SDF1 and CXCR4 in the
neonatal ovary as a result of an ovarian transcriptome
project was of particular interest to us considering the
neonatal ovary lacks mature follicles. We therefore under-
took expression and functional studies to determine what
role this chemokine and receptor play in the early stages
female germ cell development.
Materials and methods
Use of animals for this study was approved by the University of Newcastle
and University of Queensland Animal Care and Ethics Committees. All
chemicals and reagents were obtained from Sigma (Sigma, USA) or Research
Organics (Research Organics Inc., USA) unless otherwise stated. Cell culture
media and supplements were obtained from Sigma and Gibco (Gibco™
Invitrogen Corporation, Australia).
Tissue collection and RNA extraction
Embryonic, neonatal, or adult Swiss outbred mice or Quackenbush mice
were euthanized via decapitation, cervical dislocation, or CO2 asphyxiation and
organs removed and snap frozen in liquid nitrogen. RNA was extracted fromtissues using Trizol reagent (Invitrogen, Australia), according to the manufac-
turer's directions.
Microarray analysis
RNA to be used for microarray analysis was amplified from 500 ng of total
RNA using a modified van Gelder/Eberwine protocol (Gelder et al., 1990). First
strand synthesis was performed using Superscript III reagents (Invitrogen,
Australia), according to the manufacturer's directions. Second strand synthesis
was performed using Advantage 2 Taq Polymerase (BD Biosciences Clontech,
USA), according to directions, with the addition of RNase H. T7 RNA
amplification was performed using the MegaScript kit (Ambion, Inc., USA).
Following precipitation, 500 ng of RNA was subjected to a second round of
amplification using random hexamer priming. Amino-allyl labeled cDNA was
prepared from 6 μg of amplified RNA and labeled with Cy3 or Cy5 dyes using
the CyScribe Post-labeling Kit (Amersham, Sweden) according to directions.
Equivalent amounts of Cy3 and Cy5 were hybridized overnight in a humidified
chamber at 42°C to slides spotted with the NIA mouse 15 K cDNA set (AGRF,
Australia). Slides were washed once with 55°C 1× SSC, 0.2% SDS, twice in
0.1× SSC, 0.2% SDS, twice in 0.1× SSC and once in water prior to rapid drying
and scanning on an Axon Scanner (Molecular Devices Corporation, USA). Data
analysis was performed using GeneSpring Software using Lowess normaliza-
tion, using background subtraction with buffer spots as negative controls.
CodeLink microarrays
Gene expression analysis was performed utilizing CodeLink™ Mouse
Whole Genome Array slides (GE Healthcare, UK) according to the manu-
facturer's instructions. Briefly, cDNAwas generated from approximately 2 μg of
total RNA from neonatal mouse ovaries. An in vitro transcription was
performed, incorporating biotinylated UTP in the resulting amplified RNA
(aRNA). Ten micrograms of aRNA was hybridized with the Mouse Whole
Genome Slide and detection of hybridization carried out by probing with Cy5-
streptavidin. Slides were scanned in an Axon scanner and data analyzed with
proprietary CodeLink™ Expression Analysis Software (GE Healthcare, UK).
Affymetrix microarray analysis
Quackenbush mouse embryos were collected at the appropriate day and
sexed as previously described (Wilson et al., 2005). 5–10 sexed gonad pairs
were pooled into their appropriate age/sex-specific group in triplicate. Total
RNA was extracted using Qiagen's RNeasy® Micro Kit as per manufacturer's
instructions. Samples showing excessive degradation based on 260:280 ratio
(outside the 1.8–2.1 range) or the presence of a brighter 28S band than the 18S
band following agarose gel electrophoresis were disregarded. Remaining pooled
samples containing >300 ng total RNAwere used to make biotin labeled aRNA
using Ambion's MessageAmp II aRNA Amplification kit as per manufactures
instructions. aRNA was fragmented using fragmentation buffer (final concen-
tration of 1×) at 94°C for 35 min. 10 μg of aRNA samples was prepared and
hybridized on Affymetrix mouse 430v2 chips as per manufacturer's instructions
for the 49 format (Standard)/64 format arrays. Chips were hybridized for 16 h at
45°C at 60 rpm, before being washed and stained on a Fluidics Station 450 using
protocol EukGE-WS2v5. The chips were then scanned with an Agilent
GeneArray Scanner 3000 and preliminary analyzed using Affymetrix Genechip
Operating Software v1.2 (GCOS) was carried out to confirm Chip integrity,
RNA integrity and control signals. Chips were scaled to a target signal of 150 in
GCOS, and raw data in GeneSpring were normalized to the median signal using
GC-RMA normalization using a RAW signal cut-off of 0.01. CEL files from
GCOS were also analyzed in DNA-Chip Analyzer software (DChip). CEL files
were entered into DChip and normalized against the baseline array showing the
median overall intensity. Normalized data were then exported into Microsoft
Excel and plotted.
RT-PCR transcript analysis
Two micrograms of total RNA from mouse tissues was reverse transcribed
with oligo(dT)15 primer (Promega, USA) or random hexamers and M-MLV
Fig. 1. RT-PCR screen for SDF1-α, -β, and -γ transcript expression in neonatal,
adult and in vitro cultured ovaries. SDF1-α and -β were detected in ovarian
tissue, but not γ. Lung cDNAwas used as a positive control for all 3 transcripts.
β-actin PCR was performed to confirm integrity of cDNA. Products from
reactions with (+) and without (−) reverse transcriptase are shown.
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forward primer 5′-gctgccgcactttcactctc-3′ and reverse primers specific for the 3
SDF1 splice variants: SDF1-α alpha: 5′-CCACCACTGCCCTTGCATCT-3′,
SDF1-β 5′-ACATAGTGGCCTTGGCCTGT-3′ and SDF1-γ , 5′-CTTTAGCA-
GACAGAGCAGGGC-3′ with expected product sizes of 440 bp, 612 and
663 bp, respectively. The PCR reaction conditions were as follows: 1 cycle of
94°C for 5 min; 35 cycles of 95°C for 45 s, 57°C for 45 s, 72°C 45 s; 1 cycle of
72°C for 10 min. The integrity of each cDNA sample was checked by β-actin
PCR using forward primer 5′-TGGATGATGATATCGCCGCG-3′ and reverse
5′-CTAGAAGCATTTGCGGTGGACGATGGAGGGGCC-3′ using an anneal-
ing temperature of 60°C and extension time of 2 min. PCR products cloned into
the pGEM-T Easy vector (Promega, USA) prior to sequencing (AGRF,
Australia).
Real-time PCR
Total RNAwas treated with DNAse (Promega) prior to reverse transcription
as previously described. PCR was performed on an Opticon real-time
thermocycler (Bio-Rad Laboratories, Australia) using SyBr Green Mastermix
according to the manufacturers directions, using an annealing temperature of
64°C for 40 cycles. Primers used were: SDF1-α/β forward 5′-CGCTCTGCAT-
CAGTGACGGTA-3′ and reverse 5′-GTTCTTCAGCCGTGCAACAATC-3′;
CXCR4 QuantiTect Primer Assay Primers QT00249305 (Qiagen), Cyclophilin:
forward 5′-CGTCTCCTTCGAGCTGTTT-3′ and reverse 5′-ACCCTGGCA-
CATGAATCCT-3′, 18S rRNA forward 5′-CGGCTACCACATCCAAGGAA-3′
and reverse 5′-GCTGGAATTACCGCGGCT-3′ with an annealing temperature
of 64°C. Primer efficiencies of SDF1 and CXCR4 versus cyclophilin were
confirmed as being similar by correlation analysis of cycle threshold (Ct) values
of 10-fold dilutions of ovary cDNA. For expression analysis, data from 3
replicates were analyzed using the 2−ΔΔCT method.
In situ hybridization
Probes were prepared from PCR products amplified with SDF1 RT primers
and CXCR4 primers-forward: 5′-CTCCAACAAGGAACCCTGCT-3′ and
reverse: 5′-TGGCATCAACTGCCCAGAAG-3′. Inserts were cloned into
pGEM-T Easy and probes transcribed using Sp6 or T7 polymerase with
digoxygenenin-labeled ribonucleotides incorporated (Roche Molecular Bio-
chemicals, Germany). Sections were pre-treated and hybridized according to
established protocols (Yang et al., 1999). Overnight incubations were performed
at 45°C, with post-hybridization washed at 55°C (SDF1) or 50°C (CXCR4).
Probe detection was performed using an alkaline phosphatase-conjugated anti-
DIG antibody (DAKO, Denmark) (1:500) with NBT/BCIP substrate (Roche
Molecular Biochemicals, Germany). Sections were counterstained with
hematoxylin prior to mounting and photography.
Immunohistochemistry
IHC was carried out on paraformaldehyde-fixed, paraffin-embedded
sections using SDF1-α and CXCR4 polyclonal antibodies at a dilution of
1:100(Abcam Ltd., UK). Sections were incubated at 4°C overnight prior to
visualization using the Envision Plus System (DakoCytomation, Denmark)
secondary antibody and 3,3′-diaminobenzidine staining, followed by hematox-
ylin counterstaining. For dual immunostaining, primary antibodies were
incubated simultaneously followed by incubation with anti-rabbit rhodamine-
conjugated secondary antibody (1:200) then an anti-goat FITC-conjugated
antibody (1:80) (Chemicon, USA). Slides were mounted with SlowFade® Light
Antifade reagent (Molecular Probes, USA) prior to imaging with a LSM510
laser-scanning microscope (Carl Zeiss Pty) equipped with Argon and Helium/
Neon lasers at excitation wavelengths of 488 and 543 nm and emission spectra
of 500–530 nm (FITC) and greater than 560 nm (Rhodamine).
Ovarian explant culture
Ovaries were excised, their bursae removed and placed on membrane inserts
(Millipore Billerica, MA, USA) placed above 24-well tissue culture plate wells
with culture media containing DMEM/F12, 5% FCS, 0.1% BSA, ascorbic acid(50 μg/ml), insulin–transferrin–selenium, 2.5 mM glutamine and penicillin/
streptomycin (Gibco). Media were supplemented with bFGF (40 ng/ml), LIF
(50 ng/ml), SCF (25 ng/ml) with or without SDF1-α (10 ng/ml–250 ng/ml).
Ovaries were cultured for 5 days, with media changes every other day. Ovaries
were treated with recombinant mouse SDF1-α, AMD3100 or PBS alone with
fresh ligand added with each media change (R&D Systems, USA). Following
culture ovaries were fixed in 4% paraformaldehyde, paraffin-embedded and 5-
μm sections counterstained with hematoxylin and eosin. Ovaries were sectioned
in entirety and where possible sections mid-way through the block selected for
analysis. Two or more ovaries per treatment were viewed, with an average count
value taken on ovaries sections separated by 15 μm. Measurements for ovary
density and diameter were performed using an ocular micrometer. Effects of
SDF-α on follicle density or oocyte diameter were analyzed by one-way
ANOVA followed by a Tukey's HSD (honestly significant difference) test or
Student's t test, with probabilities of 0.02 or 0.05 or less considered significant.
TUNEL analysis
Paraformaldehyde-fixed sections were deparaffinized, re-hydrated and
treated with 2× SSC at 80°C for 20 min, dH2O at RT for 10 min and 0.1 M
Tris/0.05 M EDTA at 42°C for 2 min. Sections were incubated with 20 μg/ml
Proteinase K at 37°C for 10 min in a humid chamber. Slides were blocked with
1% BSA/PBS and permeabilized with 0.1% Triton X-in 10 mM sodium citrate
(pH6) at 4°C for 2 min. Fifty-microliter reaction mixes were prepared with 31 μl
MilliQ H20, 1 mM CoCl2, 60 μMATP, 0.6 μM FITC-dUTP, 1× TdT buffer, and
125 U of terminal deoxynucleotidyl transferase (TdT) enzyme (Roche
Diagnostics Pty Ltd., Australia). A reaction lacking enzyme was performed in
parallel as a negative control. Sections were incubated for 1 h at 37°C in a dark
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reagent (Molecular Probes, USA) prior to viewing.
Results
Detection of SDF-1β and cxcr4 transcripts via microarray
analysis
Expression of CXCR4 and SDF1-β was confirmed via
screening of CodeLink™ Mouse Whole Genome array slides
(GE Healthcare, UK) with 7-day mouse ovary RNA. Normal-
ized intensity values of 4.6 and 0.6 were obtained for the
receptor and ligand respectively. Differences in developmental
expression were assessed using a 2-color comparison between
2-day and 7-day neonatal ovary RNA on NIA 15K cDNA
microarray slides (AGRF, Australia). SDF1-β (BG086320) was
up-regulated 3.90-fold (±SE 0.46) and CXCR4 (BG063365)
up-regulated 2-fold (±SE 0.37). Other SDF1 transcript variants
were not present on either microarray. Real-time PCR analysis
confirmed the up-regulation of the ligand gene expression with
1.81 (±SE 0.20)-fold difference. CXCR4 expression was also
consistently up-regulated with a mean 1.49 (±SE 0.40)-fold
increase in expression. The high variation detected between
array and real-time PCR replicates is likely to reflect the
differences in numbers of activated versus non-activated
follicles per experiment.Fig. 2. Localization of SDF1-α/β and CXCR4 transcript expression in neonatal ov
revealed similar expression patterns for CXCR4 (A: antisense, B: sense probe) an
follicles. Scale bar = 20 μM.RT-PCR analysis of SDF1 and CXCR4-transcript variants
present in mouse ovary
Detection of SDF1-β in the microarray analysis prompted
the search for other SDF1 transcript variants not present in the
NIA cDNA clone set. RT-PCR confirmed the presence of SDF1
transcript variants 1 and 2 (SDF-α and -β) in cultured, neonatal
and adult ovary cDNA samples in addition to the lung cDNA-
positive control. SDF transcript variant 3 (SDF-γ) could not be
detected in ovarian tissue but was present in lung tissue (Fig. 1).
Cellular localization of SDF1 and CXCR4 receptor mRNA and
protein in ovarian tissue
Both receptor and ligand messages displayed highly similar
expression patterns in neonatal ovarian tissue. Messenger RNA
was detected prominently in the oocytes of primordial and
primary/secondary oocytes, with lower levels of staining in the
interstitial tissue and granulosa cells (Fig. 2). CXCR4 protein
was detected in the oocytes and granulosa cells of primordial
and activated follicles (Fig. 3A). SDF1 immunostaining
revealed a highly similar protein expression pattern, with
intensity of staining increasing with follicle size (Fig. 3B). Dual
immunostaining assessed using multi-tracking confocal scan-
ning microscopy confirmed oocyte expression of both ligand
and receptor (Figs. 3C–E).arian tissue. In situ hybridization using DIG-labeled antisense or sense probes
d ligand (C: antisense, D: sense probe) transcripts in primordial and activated
Fig. 3. Expression of CXCR4 (A) and SDF1-α (B) protein in 7-day neonatal mouse ovarian tissue. Polyclonal antibodies to CXCR4 and SDF1-α revealed similar
patterns of protein expression for both receptor and ligand. Staining indicates protein presence predominantly in primordial follicle oocytes as well as activated oocytes
and cuboidal granulosa cells, with some staining for receptor and ligand in pre-granulosa cells and stromal tissue. SDF1-α staining intensity in follicles increases with
developmental stage of the oocyte. Scale bar = 20 μm. Dual immunohistochemistry (C–E) confirmed colocalization of SDF1-α/CXCR4. Confocal images of CXCR4
immunolabeling (C), SDF1-α (D) and colocalization (E), scale bar upper panel = 20 μM, scale bar lower panel = 10 μM.
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ligand and receptor is established in the murine gonad, mRNA
expression in both the female and male gonad was analyzed by
microarray and real-time PCR analysis on embryonic gonads.Table 1
Results of Affymetrix microarray analysis of SDF1 transcript variants in the 11.5, 1
Female
11.5 dpc 12.5 dpc 13.5 dpc
SDF-α 1390 ± 39 828 ± 125 681 ± 86
SDF-β 1740 ± 56 918 ± 143 401 ± 53
SDF-γ 48 ± 10 44 ± 10 43 ± 8
Affymetrix signal values plus and minus the standard error of the mean are given. N
examined. Similar levels of SDF1-α and -β were detected in the male and female at t
observed over the time period 11.5 to 13.5 for the female. A decrease in SDF1-α and -
period for the male.Affymetrix microarray screening of 11.5 dpc, 12.5 dpc, and
13.5 dpc embryos revealed high levels of expression of SDF-α
and -β over the time period in both gonads, with negligible
levels of SDF1-γ (Table 1). For further evaluation of trends in2.5, and 13.5 dpc male and female mouse embryonic gonad
Male
11.5 dpc 12.5 dpc 13.5 dpc
1428 ± 249 1022 ± 88 2433 ± 105
1830 ± 313 1261 ± 93 1773 ± 40
40 ± 15 39 ± 5 36 ± 10
egligible SDF1-γ levels were detected in either sex for any of the time points
he first time point of 11 dpc. A trend of decreasing levels of SDF1-α and β was
β levels in the male was followed by an increase and observed over the same time
Fig. 4. Real-time PCR analysis of SDF1-α/β transcript in embryonic mouse gonads. From 12.5 to 17.5 dpc, a dichotomous expression pattern exists between the male
and female gonad. A statistically significant increase in the levels of SDF1-α/β expression was observed over time for the male (up to day 15.5 dpc), which decreased by
day 17.5. After initially similar levels of SDF1-α/β at day 11.5 dpc, levels in the female decreased and remained low to undetectable by day 17.5 dpc (P < 0.02).
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same time period as well as days 15.5 dpc and 17.5 dpc. Primers
were designed for dual detection of SDF1-α and SDF1-β
transcripts considering their congruous pattern of expression in
the Affymetrix microarray data. Real-time PCR analysis
revealed a highly dichotomous SDF1 expression pattern
between the male and female gonad. Low to negligible levels
of transcripts were present after 11.5 dpc in the female gonad,
with a significant increase in expression from 11.5 dpc to
15.5 dpc in the male gonad followed by a decrease by 17.5 dpc
(Fig. 4). Immunohistochemistry confirmed protein expression
of both ligand and receptor in the differentiated male gonad
(Fig. 5). The consistent staining pattern indicated expression in
both the germ and somatic cells of the male tubule with little
interstitial cell staining. Low levels of staining suggested
CXCR4 and SDF1 proteins were also present in the female
differentiated gonad in both germ cells and somatic cells. The
lack of transcript at these time points indicates this may
represent remnant protein from the time period corresponding to
completion of primordial germ cell migration and colonization
of the indifferent gonad (∼11.dpc).
Effect of recombinant SDF1-α and CXCR4 inhibitor AMD3100
on cultured neonatal ovaries
The ovarian culture media used for this study allowed for
significant, but not exhaustive, levels of follicle activation in
neonatal Swiss outbred mouse ovaries. Factors were included
that have previously been shown to enhance follicle activation
such as LIF, bFGF, and SCF (Nilsson et al., 2001, 2002; Parrott
and Skinner, 1999). These were considered necessary for
optimal ovary health while still allowing a mixture of primordial
and primary follicles to survive, therefore allowing for an
analysis of either an enhancement or repression of follicle
activation.
Incubation with recombinant SDF1-α resulted in a dose-
dependent increase in follicle densities for additions in therange of 10 to 250 ng/ml of SDF1-α (Fig. 6A). In contrast,
treatment of ovaries with a CXCR4 specific antagonist of
SDF1 binding, AMD3100, in the presence of 250 ng/ml of
SDF1-α reduced follicles densities back to control levels
(Fig. 6B).
In order to determine whether the increase in follicle
densities was a result of a decrease in follicular apoptosis in
response to SDF1-α, TUNEL assays were performed on
cultured ovarian sections. Similar levels of apoptotic cell
staining for control and ovaries treated with 250 ng/ml SDF1-α
were observed (Fig. 7). The low-level, sporadic TUNEL
labeling was not indicative of necrotic tissue thereby confirming
the healthy status of the cultured ovaries. Staining occurred
primarily in somatic cells as determined by morphological
assessment.
To test the alternative hypothesis that the higher follicle
densities seen in treated ovaries were a result of a block in
follicle activation, measurements of oocyte follicle diameters of
control and 250 ng/ml SDF1-α treated explants were assessed.
Oocyte growth is an established marker of follicle activation
together with the transition of granulosa cells from squamous to
cuboidal morphology and subsequent proliferation (Lintern-
Moore and Moore, 1979). A difference in the distribution
pattern of oocyte diameters was indeed obtained, with control
ovaries displaying a shift toward larger oocyte sizes in
comparison with ovaries treated with 250 ng/ml SDF1-α
(Fig. 8A). A statistically significant difference (P < 0.05)
was obtained for numbers of oocytes greater than or equal
to 24 μm in diameter between control and 250 ng/ml SDF1-
α treated (Fig. 8B).
Discussion
The detection of a chemokine receptor and ligand in the
neonatal ovary was an intriguing discovery as chemokines have
received little attention as candidates for regulators of early
female germ cell development. Rather, the focus has been on
Fig. 5. Expression of SDF1-α and CXCR4 protein in mouse embryonic gonad tissue. Staining indicates protein present in all cell types of the female gonad at
13.5–14.5 dpc and 16.5–17.5 dpc, and in spermatogonia and Sertoli cells of the male gonad. Cells marked with arrows are examples of oogonia. Scale bar = 20 μM.
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immune cells and inflammatory response. (Townson and
Liptak, 2003a,b; Wu et al., 2004a).Following detection of the SDF1-β transcript in the
neonatal ovary, we sought to establish whether other SDF1
transcripts were also present, in particular SDF1-α which is
Fig. 6. (A) Effect of rSDF1-α on follicle density of 5-day cultured mouse ovaries. A dose-dependent increase in follicle density was observed following treatment with
SDF1-α up to 250 ng/ml. (B) Treatment of cultured ovaries with CXCR4 antagonist AMD3100 (100 μM) in combination with SDF1-α (250 ng/ml) resulted in
significantly lower follicle densities than ovaries treated with SDF1-α alone. Treatment with AMD3100 in combination with SDF1-α gave follicle densities similar to
those of control ovaries or those treated with AMD3100 alone. Significance (P < 0.02) between groups is represented by different letters.
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Abundant expression of SDF1-α and -β transcripts has been
reported in the adult human ovary (Shirozu et al., 1995). Both
SDF1-α and SDF1-β but not SDF1-γ were detected in
neonatal, cultured, and adult mouse ovarian tissue (Fig. 1).
The lack of SDF1-γ in mouse ovarian tissue was not
unexpected given that SDF1-β and -γ have previously been
shown to be inversely expressed in somatic tissues of the
adult rat (Gleichmann et al., 2000). The authors reported a
lack of SDF1-α and differential expression of SDF1-β and -γ
in the brain during rat embryogenesis, suggesting that
expression of various SDF1 transcripts and protein has
important functional relevance. As SDF1-α is the best
characterized SDF transcript variant in the literature, it was
selected as the isoform for localization and functional studies.
That SDF1-β is playing a distinct role in the developing
ovary cannot, however, be discounted. For example, migrat-ing primordial germ cells in the chick embryo can be directed
by SDF1-α but not SDF1-β (Stebler et al., 2004).
Both SDF1-α and CXCR4 mRNA and protein localized
to the primordial and primary follicles. The uniformity of
gene expression across different stage follicles by in situ
hybridization indicated SDF1 and CXCR4 transcripts may
not necessarily be up-regulated upon follicle activation. The
apparent up-regulation may be due to the greater
proportion of oocyte cytoplasmic volume in the 7-day
ovary compared with the 2-day ovary, due the rapid
enlargement of the oocyte once activated. The detection of
both transcripts in the primordial follicle oocyte was
nonetheless interesting as the primordial oocyte is essen-
tially a “resting” cell with relatively limited metabolic
capability (Moore et al., 1974; Oakberg, 1968), suggesting
that the chemokine and receptor may be performing an
essential role within the follicle.
Fig. 7. Effect of 250 ng/ml SDF1-α on levels of apoptosis in the neonatal 5-day
cultured ovary. TUNEL analysis indicated no observable differences in cellular
apoptosis between SDF1-α treated ovaries (A) and PBS-treated control ovaries
(B). A reaction lacking Tdt enzyme was included as a negative control (C). Scale
bar = 40 μm.
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on the expression of the ligand by the dorsal body wall,
particularly in the mesonephros and adjacent mesenchyme
tissue, which aids in directing the primordial germ cells to the
embryonic gonad (Molyneaux et al., 2003; Stebler et al.,
2004). In order to gain insight into when dual expression of
ligand and receptor in the gonad first occurs, we analyzed
SDF1 expression in the male and female embryonic gonad,
pre- and post-differentiation. SDF1-α/β transcripts were
detected via Affymetrix array screening in both sexes over
a broad time period corresponding to the latter migratory
period (11.5 dpc), gonad colonization/beginning of differen-
tiation (12.5 dpc), female meiotic I entry (13.5 dpc), and post-differentiation (17.5 dpc). In agreement with the post-natal
ovary SDF1 transcript profile, SDF-γ expression was
negligible. Real-time PCR confirmed SDF1 expression at
similar levels in the 11.5 dpc indifferent gonad of both sexes.
In agreement with this, Stebler et al. (2004) reported the
presence of SDF-α and -β in the genital ridges of embryos of
this stage, where its expression is likely to be required for the
attraction of the primordial germ cells to the indifferent gonad
(11.5 dpc). We report for the first time the SDF1 pattern of
expression in the mouse in the later stages of embryonic
gonadal development. Surprisingly, colonization and the
beginning of gonadal differentiation (12.5 dpc onwards)
marked the beginning of a highly dichotomous expression
pattern between the sexes, with little to no SDF1 transcript
detected in the female gonad past this stage in contrast to the
male gonad. These high levels of SDF1 suggest that the
ligand may play an important yet unidentified role in the
differentiating male gonad distinct from the initial primordial
germ cell attractive role which has been established for SDF1.
The ligand may be less important in the developing female
gonad considering the negligible levels of SDF1 transcript in
the female. This is not conclusive however, due to the
detection of protein in the differentiating female gonad
(13.5 dpc onwards), although this may be residual protein
from earlier stages. It is interesting to note that protein was
localized in germ cells, which suggests that the ligand begins
to be expressed in this cell at some point after migration,
between the time of colonization and the start of differenti-
ation, and suggests that the autocrine SDF1/CXCR4 axis in
the female germ cell is established well before primordial
follicle assembly and activation.
An autocrine pattern of expression for CXCR4 and SDF1
is not unique and has been described in human thyroid
carcinoma cell lines (Hwang et al., 2003) and human
trophoblasts (Wu et al., 2004b).The expression profile we
have seen overlaps a broad developmental time period in the
female germ cell life cycle encompassing the processes the
mitotic division, meiotic I entry and meiotic I arrest within
the developing gonad. Although a paracrine SDF1/CXCR4
signaling system has been reported to function in germ cell
migration, the switch to an autocrine pattern of expression
may herald a concomitant change in function. Our study did
not address function in the embryonic gonad; however an
anti-apoptotic or pro-angiogenic role could be envisaged.
Activation of SDF1/CXCR4 signaling pathways influences a
plethora of cellular processes including chemotaxis, secre-
tion, adhesion, cell survival, through activation of PLC, PI3
kinase, and MAPK/ERKs and varies greatly with cell type
(Kucia et al., 2004; Murdoch, 2000; Scotton et al., 2002).
Our study sought to instead establish a functional role for
CXCR4/SDF upon the newly formed primordial follicle pool
which represents the limited source from which mature female
gametes may arise. Once primordial follicles activate, they are
destined to enter the growing follicle pool, or undergo atresia.
Greater than 99% of all follicles that enter the growing pool die,
thus making the maintenance of the primordial follicle pool a
crucial determinant of the reproductive lifespan of the
Fig. 8. Effect of SDF1-α on oocyte diameter a marker of follicular growth and activation. (A) Histogram of oocyte diameters taken from 3 experiments, demonstrating
a shift toward larger oocytes in control ovaries compared with SDF1-α treated ovaries. (B) There was a statistically significant difference in numbers of oocytes 24 μm
and above, between control and SDF1-α treated ovaries (P < 0.05).
458 J.E. Holt et al. / Developmental Biology 293 (2006) 449–460mammalian female (Faddy et al., 1983; Gosden et al., 1983;
Tilly, 2001).
Treatment of neonatal ovaries in culture resulted in greater
follicle densities, and follicles of smaller size following
SDF1-α exposure, suggesting the chemokine is acting as an
inhibitor of follicle activation. Moreover, this effect is
specifically mediated by signaling through CXCR4, since
the CXCR4 specific antagonist AMD3100 abrogates this
effect. The lower follicle density and larger follicles seen in
untreated control ovaries suggests that more follicles are able
to activate in the absence of high levels of SDF1-α and enter
the follicle development cycle, although they cannot survive
beyond the secondary stage in the whole organ culture system
used in this study.
The only other reported inhibitor of primordial follicle
activation is the TGFβ superfamily-member, anti-Müllerian
hormone (AMH). In contrast to SDF1, AMH acts in a
paracrine manner, with protein expressed by the granulosacells of activated follicles only (Durlinger et al., 2002b).
Similarly to AMH, our findings indicate that primordial
follicle activation is not completely attenuated by either
SDF1-α alone, highlighting the fact that the activation process
is influenced by a balance of both stimulatory and inhibitory
factors.
In conclusion, the results of this study demonstrate the
autocrine expression of the chemokine SDF1-α and its
receptor CXCR4 in the female gamete, during early
developmental and perinatal period of the mouse female
germ cell development and indicate that the signaling axis
may play an important role inhibiting follicle activation.
Further studies will elucidate the signaling pathways involved
in this process and the interactions with other key factors
implicated in the primordial to primary follicle transition.
Additionally, an important role for SDF1/CXCR4 in the
developing male gonad distinct from a migratory role is
predicted and is currently being explored.
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